Clinical Trial: Pharmacokinetic, Safety and Immunogenicity Study of CMAB015 and Cosentyx in Healthy Volunteers
Study Status: Completed
Recruit Status: RECRUITING
Condition: Psoriasis
Study Type: INTERVENTIONAL
Official Title: Phase I Comparison of Pharmacokinetics, Safety, and Immunogenicity of CMAB015 Injection and Cosentyx in a Randomized, Double-blind, Parallel Controlled, Single-dose Study in Healthy Chinese Male Subje
Brief Summary:
This is a randomized, double-blinded, controlled Phase I study of CMAB015 administered by subcutaneous injection.This study will characterize the pharmacokinetic, safety and immunogenicity of CMAB015 versus Cosentyx?Secukinumab ? in healthy male subjects after a single dose.
Read more